
<ns0:uwmetadata xmlns:ns0="http://phaidra.univie.ac.at/XML/metadata/V1.0" xmlns:ns1="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0" xmlns:ns10="http://phaidra.univie.ac.at/XML/metadata/provenience/V1.0" xmlns:ns11="http://phaidra.univie.ac.at/XML/metadata/provenience/V1.0/entity" xmlns:ns12="http://phaidra.univie.ac.at/XML/metadata/digitalbook/V1.0" xmlns:ns13="http://phaidra.univie.ac.at/XML/metadata/etheses/V1.0" xmlns:ns2="http://phaidra.univie.ac.at/XML/metadata/extended/V1.0" xmlns:ns3="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/entity" xmlns:ns4="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/requirement" xmlns:ns5="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/educational" xmlns:ns6="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/annotation" xmlns:ns7="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/classification" xmlns:ns8="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/organization" xmlns:ns9="http://phaidra.univie.ac.at/XML/metadata/histkult/V1.0">
  <ns1:general>
    <ns1:identifier>o:34916</ns1:identifier>
    <ns1:title language="en">Phosphorylated neurofilament heavy chain in cerebrospinal fluid and plasma in clinically silent and childhood-onset SMA individuals from Serbia</ns1:title>
    <ns2:alt_title language="sr">Fosforilisani teški lanac neurofilamenta u cerebrospinalnoj tečnosti i plazmi kod bolesnika iz Srbije sa klinički neispoljenom i SMA sa početkom u detinjstvu</ns2:alt_title>
    <ns1:language>en</ns1:language>
    <ns1:description language="en">ABSTRACT
Biomarkers capable of reflecting disease onset and short- and long-term therapeutic effects in individuals with spinal muscular atrophy (SMA) are still an unmet need and phosphorylated neurofilament heavy chain (pNF-H) holds significant promise. We conducted a longitudinal prospective study to evaluate pNF-H levels in the cerebrospinal fluid (CSF) and plasma of 29 individuals with childhood-onset SMA treated with Nuinersen (SMA type 1: n=6, type 2: n=17, type 3: n=6). pNF-H levels before and during treatment were compared with the levels of controls (n=22), patients with Duchenne muscular dystrophy (n=17), myotonic dystrophy type 1 (n=11), untreated SMA individuals with chronic type 3 disease (n=8), and children with presymptomatic SMA (n=3). SMA type 1 showed the highest mean CSF pNF-H levels before treatment initiation. </ns1:description>
    <ns1:keyword language="en">neurofilament, spinal muscular atrophy, Nuinersen, pNF-H</ns1:keyword>
    <ns2:identifiers>
      <ns2:resource>1552099</ns2:resource>
      <ns2:identifier>10.1016/j.nmd.2024.07.600</ns2:identifier>
    </ns2:identifiers>
    <ns2:identifiers>
      <ns2:resource>1552101</ns2:resource>
      <ns2:identifier>0960-8966</ns2:identifier>
    </ns2:identifiers>
  </ns1:general>
  <ns1:lifecycle>
    <ns1:upload_date>2024-10-18T08:31:07.053Z</ns1:upload_date>
    <ns1:status>44</ns1:status>
    <ns2:peer_reviewed>yes</ns2:peer_reviewed>
    <ns1:contribute seq="0">
      <ns1:role>46</ns1:role>
      <ns1:entity seq="0">
        <ns3:firstname>M.</ns3:firstname>
        <ns3:lastname>Brkušanin</ns3:lastname>
        <ns3:institution>University of Belgrade, Faculty of Biology, Centre for Human Molecular Genetics, Belgrade, Serbia</ns3:institution>
      </ns1:entity>
      <ns1:entity seq="1">
        <ns3:firstname>D.</ns3:firstname>
        <ns3:lastname>Savić-Pavićević</ns3:lastname>
        <ns3:institution>University of Belgrade, Faculty of Biology, Centre for Human Molecular Genetics, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="2">
        <ns3:firstname>V.</ns3:firstname>
        <ns3:lastname>Milić-Rasić</ns3:lastname>
        <ns3:institution>Clinic for Neurology and Psychiatry for Children and Youth, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="3">
        <ns3:firstname>G.</ns3:firstname>
        <ns3:lastname>Brajušković</ns3:lastname>
        <ns3:institution>University of Belgrade, Faculty of Biology, Centre for Human Molecular Genetics, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="4">
        <ns3:firstname>Z.</ns3:firstname>
        <ns3:lastname>Stević</ns3:lastname>
        <ns3:institution>University of Belgrade-School of Medicine, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="5">
        <ns3:firstname>D.</ns3:firstname>
        <ns3:lastname>Nikolić</ns3:lastname>
        <ns3:institution>University Children&apos;s Hospital Tirsova, University Clinical Centre of Serbia, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="6">
        <ns3:firstname>Z.</ns3:firstname>
        <ns3:lastname>Dobrijević</ns3:lastname>
        <ns3:institution>University of Belgrade, Institute for the Application of Nuclear Energy INEP, Serbia</ns3:institution>
        <ns3:title1>doktor bioloških nauka</ns3:title1>
        <ns3:type>person</ns3:type>
        <ns3:orcid>0000-0002-4652-7719</ns3:orcid>
      </ns1:entity>
      <ns1:entity seq="7">
        <ns3:firstname>L.</ns3:firstname>
        <ns3:lastname>Radenković</ns3:lastname>
        <ns3:institution>University of Belgrade, Faculty of Biology, Centre for Human Molecular Genetics, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="8">
        <ns3:firstname>N.</ns3:firstname>
        <ns3:lastname>Radovanović</ns3:lastname>
        <ns3:institution>University of Belgrade, Faculty of Biology, Centre for Human Molecular Genetics, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="9">
        <ns3:firstname>J.</ns3:firstname>
        <ns3:lastname>Pešović</ns3:lastname>
        <ns3:institution>University of Belgrade, Faculty of Biology, Centre for Human Molecular Genetics, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="10">
        <ns3:firstname>N.</ns3:firstname>
        <ns3:lastname>Garai</ns3:lastname>
        <ns3:institution>University of Belgrade, Faculty of Biology, Centre for Human Molecular Genetics, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="11">
        <ns3:firstname>S.</ns3:firstname>
        <ns3:lastname>Matijašević Joković</ns3:lastname>
        <ns3:institution>University of Belgrade, Faculty of Biology, Centre for Human Molecular Genetics, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="12">
        <ns3:firstname>J.</ns3:firstname>
        <ns3:lastname>Karanović</ns3:lastname>
        <ns3:institution>University of Belgrade, Faculty of Biology, Centre for Human Molecular Genetics, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="13">
        <ns3:firstname>K.</ns3:firstname>
        <ns3:lastname>Jovanović</ns3:lastname>
        <ns3:institution>University Children&apos;s Hospital Tirsova, University Clinical Centre of Serbia, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="14">
        <ns3:firstname>V.</ns3:firstname>
        <ns3:lastname>Branković-Srećković</ns3:lastname>
        <ns3:institution>Clinic for Neurology and Psychiatry for Children and Youth, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="15">
        <ns3:firstname>A.</ns3:firstname>
        <ns3:lastname>Kosač</ns3:lastname>
        <ns3:institution>Clinic for Neurology and Psychiatry for Children and Youth, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
    </ns1:contribute>
  </ns1:lifecycle>
  <ns1:technical>
    <ns1:format>application/pdf</ns1:format>
    <ns1:size>810131</ns1:size>
    <ns1:location>https://phaidrabg.bg.ac.rs/o:34916</ns1:location>
  </ns1:technical>
  <ns1:rights>
    <ns1:cost>no</ns1:cost>
    <ns1:copyright>yes</ns1:copyright>
    <ns1:license>1</ns1:license>
  </ns1:rights>
  <ns1:classification>
    <ns1:purpose>70</ns1:purpose>
  </ns1:classification>
  <ns1:organization>
    <ns8:hoschtyp>92000004</ns8:hoschtyp>
    <ns8:orgassignment>
      <ns8:faculty>11A02</ns8:faculty>
    </ns8:orgassignment>
    <ns8:orgassignment>
      <ns8:faculty>11A29</ns8:faculty>
      <ns8:department>11A2905</ns8:department>
    </ns8:orgassignment>
    <ns8:orgassignment>
      <ns8:faculty>11A32</ns8:faculty>
    </ns8:orgassignment>
  </ns1:organization>
  <ns12:digitalbook>
    <ns12:name_magazine language="en">29th World Muscle Society Congress Prague, Czechia, 2024-Neuromuscular Disorders</ns12:name_magazine>
    <ns12:volume>43</ns12:volume>
    <ns12:publisher>Elsevier B.V.</ns12:publisher>
    <ns12:releaseyear>2024</ns12:releaseyear>
  </ns12:digitalbook>
</ns0:uwmetadata>
